Christopher Beal, DO
Interventional Pain Medicine · West Columbia, SCNPI 1992115935
Payments from drug & device makers
What this record shows
This record is dominated by grants: $2,000 of the $2,421 with a category attached, or 82.6%. Medtronic accounts for 93.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $2,256 and has fallen 98.3% since, to $38 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in SC, where the typical reported total is $3,940.
Across 10 payments — averaging $242.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$110
- SPR Therapeutics, Inc$23
- Vertos Medical, Inc.$18
What the payments were for
- Grants$2,00083%
- Food & beverage$35114%
- Education$703%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 5 | $2,270 |
| Abbott | 3 | $110 |
| SPR Therapeutics, Inc | 1 | $23 |
| Vertos Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$2,000
- INTELLIS$110
How this compares
$2,421 in reported general payments places this provider in the 35th percentile of 38 interventional pain medicine providers in South Carolina.
See all interventional pain medicine providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 248 | $4,175 |
| Gabapentin | 207 | $2,725 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 98 | $1,519 |
| Lidocaine | 17 | $1,487 |
| Pregabalin | 70 | $1,002 |
| Baclofen | 66 | $953 |
| Diclofenac Sodium | 65 | $917 |
| Duloxetine Hcl | 43 | $889 |
| Tizanidine Hcl | 96 | $861 |
| Cyclobenzaprine Hcl | 27 | $279 |
| Methocarbamol | 13 | $159 |
| Nortriptyline Hcl | 16 | $113 |
| Tramadol Hcl | 19 | $85 |
| Lorazepam | 66 | $75 |
| Oxycodone Hcl | 11 | $75 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in West Columbia
- Kenneth GrosslightWest Columbia$7K
- Jialiu LiWest Columbia$4K
- Russell BinghamWest Columbia$3K
- Robert DetersWest Columbia$164
- Mark NethertonMt Pleasant$102K
- Marion McMillanSeneca$89K
- Jason RosenbergMurrells Inlet$82K
- Ryan NoblesMt Pleasant$43K
- Justin HutchesonGreenville$23K
- Joshua BighamSpartanburg$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.